Botanical species · safety record

Nymphaea nouchali

The EFSA Compendium of Botanicals holds 4 constituent measurements and 1 adverse-effect record for Nymphaea nouchali. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Nymphaea nouchali var. caerulea (Savigny) Verdc.

4Constituent measurements
1Safety records
4Cited sources
6Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 6 licensed products naming Nymphaea nouchali as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Flower

What the records describe

Constituents measured

  • Tannins2
  • Alkaloids1
  • Lectins1

Plant parts

  • Leaves2
  • Roots and other underground parts used as staple food1
  • Seed1
  • Unspecified1

Preparations

  • Solvent extraction4

Effect types

  • Neurotoxicity1

Target tissues

  • Brain1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
LectinsRoots and other underground parts used as staple foodStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
TanninsSeedSolvent extraction195.8 Milligram/gramUV/VIS spectroscopy (photometry)Resolve DOI
AlkaloidsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NeurotoxicityBrainUnspecifiedSolvent extractionHuman (as organism)OtherNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Lakshmi, G., Smitha, N., Ammu, S.V., Priya, C.L., Bhaskara Rao, K.V. Phytochemical profile, in vitro antioxidant and hemolytic activities of various leaf extract of Nymphaea Nouchali Linn: An in vitro study. International journal of pharmacy and pharmaceutical sciences, 2014, vol. 6, no. 6, p. 548-552.
  2. Simonienko, K., Waszkiewicz, N., Szulc, A. Psychoactive plant species - Actual list of plants prohibited in Poland Roslinne srodki odurzajace - Aktualnie obowiazujaca lista w Polsce . Psychiatria polska, 2013, vol. 47, no. 3, p. 499-510.
  3. Kabir, Syed Rashel., Abu Zubair, Md., Nurujjaman, Md., Haque, Md. Azizul., Hasan, Imtiaj., Islam, Md. Farhadul., Hossain, Md. Tanvir., Hossain, Md. Anowar., Rakib, Md. Abdur., Alam, Mohammad Taufiq., Shaha, Ranajit Kumar., Hossain, Md. Tofazzal., Kimura, Yoshinobu., Absar, Nurul. Purification and characterization of a Ca2+-dependent novel lectin from Nymphaea nouchali tuber with antiproliferative activities . Bioscience reports, 2011, vol. 31, no. 6, p. 465-475. DOI
  4. Parimala, Mabel., Shoba, Francis Gricilda. Phytochemical analysis and in vitro antioxidant acitivity of hydroalcoholic seed extract of Nymphaea nouchali Burm. f. . Asian pacific journal of tropical biomedicine, 2013, vol. 3, no. 11, p. 887-895. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue